Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 16 04:00PM ET
6.23
Dollar change
-0.12
Percentage change
-1.89
%
IndexRUT P/E18.09 EPS (ttm)0.34 Insider Own23.12% Shs Outstand146.23M Perf Week-11.25%
Market Cap915.56M Forward P/E14.49 EPS next Y0.43 Insider Trans-0.23% Shs Float112.98M Perf Month-20.94%
Income51.47M PEG1.21 EPS next Q0.04 Inst Own41.79% Short Float4.58% Perf Quarter-22.90%
Sales321.48M P/S2.85 EPS this Y-13.51% Inst Trans3.14% Short Ratio6.66 Perf Half Y-1.74%
Book/sh0.98 P/B6.38 EPS next Y34.37% ROA27.30% Short Interest5.18M Perf Year88.22%
Cash/sh0.56 P/C11.17 EPS next 5Y15.00% ROE51.59% 52W Range3.31 - 9.27 Perf YTD-28.96%
Dividend Est.- P/FCF36.93 EPS past 5Y- ROI26.85% 52W High-32.79% Beta1.43
Dividend TTM- Quick Ratio3.11 Sales past 5Y-1.19% Gross Margin82.77% 52W Low88.22% ATR (14)0.27
Dividend Ex-Date- Current Ratio3.57 EPS Y/Y TTM231.80% Oper. Margin9.08% RSI (14)23.94 Volatility3.72% 3.78%
Employees895 Debt/Eq0.35 Sales Y/Y TTM20.03% Profit Margin16.01% Recom1.00 Target Price12.50
Option/ShortYes / Yes LT Debt/Eq0.34 EPS Q/Q1984.41% Payout0.00% Rel Volume0.63 Prev Close6.35
Sales Surprise2.01% EPS Surprise344.44% Sales Q/Q16.75% EarningsApr 30 AMC Avg Volume777.30K Price6.23
SMA20-14.84% SMA50-19.73% SMA200-17.44% Trades Volume487,711 Change-1.89%
Date Action Analyst Rating Change Price Target Change
Mar-07-24Initiated Lake Street Buy $12
Oct-27-23Initiated Craig Hallum Buy $12
Oct-13-22Initiated Mizuho Buy $7
Jul-26-21Initiated Northland Capital Outperform $23
Mar-19-21Initiated H.C. Wainwright Buy $20
Apr-16-24 08:00AM
Apr-01-24 04:37PM
Mar-27-24 08:00AM
Mar-20-24 07:00AM
Mar-13-24 08:00AM
08:00AM Loading…
Mar-04-24 08:00AM
Feb-29-24 10:49AM
Feb-28-24 04:55PM
04:41PM
04:01PM
Feb-21-24 11:51PM
Feb-20-24 08:00AM
Feb-13-24 12:58PM
Feb-12-24 08:00AM
Jan-22-24 08:00AM
10:25AM Loading…
Jan-17-24 10:25AM
Dec-29-23 05:12PM
05:00PM
Dec-28-23 08:00AM
Nov-13-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:09AM
07:28AM
06:50AM
Oct-30-23 06:03PM
04:50PM
04:01PM
Oct-27-23 10:01AM
Oct-16-23 08:00AM
Sep-26-23 08:00AM
08:00AM Loading…
Sep-05-23 08:00AM
Aug-15-23 04:01PM
Aug-08-23 02:05PM
Aug-02-23 08:53AM
06:36AM
Aug-01-23 04:07PM
04:01PM
Jul-26-23 01:30PM
Jul-18-23 08:00AM
Jul-11-23 08:30AM
Jul-05-23 08:00AM
Jul-03-23 03:59AM
Jun-27-23 06:46AM
Jun-22-23 11:13AM
Jun-20-23 04:01PM
May-25-23 01:29PM
May-03-23 09:22AM
07:21AM
May-02-23 04:17PM
04:01PM
Apr-18-23 08:00AM
Apr-13-23 08:29AM
Mar-23-23 04:01PM
Mar-16-23 08:00AM
Mar-03-23 11:17AM
05:17AM
Mar-01-23 11:22AM
10:13AM
04:21AM
Feb-28-23 04:01PM
Feb-15-23 08:00AM
Jan-31-23 05:38AM
Jan-30-23 08:00AM
Jan-09-23 08:02AM
Jan-04-23 04:01PM
Jan-03-23 08:00AM
Dec-08-22 08:00AM
Nov-10-22 08:00AM
Nov-03-22 06:32AM
Nov-02-22 04:15PM
08:03AM
Oct-19-22 08:00AM
Oct-04-22 08:00AM
Sep-23-22 11:18AM
Sep-22-22 10:10AM
Sep-20-22 08:00AM
Sep-19-22 07:00AM
Sep-12-22 04:30PM
12:59PM
05:13AM
Sep-06-22 07:00AM
Aug-26-22 09:00AM
Aug-04-22 04:07PM
05:30AM
Aug-02-22 04:05PM
Jul-27-22 08:00AM
Jul-24-22 10:38AM
Jul-20-22 08:00AM
Jul-18-22 09:35AM
Jun-15-22 08:30AM
Jun-14-22 05:16PM
Jun-07-22 04:05PM
02:42PM
Jun-03-22 08:00AM
Jun-02-22 08:03AM
May-31-22 04:05PM
02:05PM
08:00AM
May-25-22 05:26PM
May-20-22 09:00AM
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hulse William Frank IVGeneral Counsel and CAOMar 13 '24Sale7.9520,381162,029479,959Mar 15 06:35 PM
Whitlow Ricci SChief Operating OfficerFeb 20 '24Sale8.0115,271122,351401,050Feb 21 04:40 PM
Whitlow Ricci SChief Operating OfficerFeb 16 '24Sale8.0715,493125,075416,321Feb 21 04:40 PM
Whitlow Ricci SChief Operating OfficerFeb 15 '24Sale8.0615,198122,496431,814Feb 16 04:22 PM
Whitlow Ricci SChief Operating OfficerFeb 14 '24Sale8.0315,845127,267447,012Feb 16 04:22 PM
DOUG RICEChief Financial OfficerNov 21 '23Buy7.165,00035,786102,200Nov 22 05:01 PM
Stein Robert BenjaminPresident, Regenerative Med.May 16 '23Sale5.9510,36561,627317,803May 17 06:26 PM
Stein Robert BenjaminPresident, Regenerative Med.May 15 '23Sale6.153,60722,170328,168May 17 06:26 PM
Carlson Peter MChief Financial OfficerMay 10 '23Sale5.935,97635,414656,435May 12 06:50 PM
Hulse William Frank IVGeneral Counsel and CAOMay 10 '23Sale5.935,87034,786456,564May 12 06:58 PM
Stein Robert BenjaminPresident, Regenerative Med.May 10 '23Sale5.935,86934,780331,775May 12 06:56 PM
Phelan William LawrenceChief Accounting OfficerMay 10 '23Sale5.931,5959,452184,219May 12 06:53 PM
Stein Robert BenjaminPresident, Regenerative Med.May 04 '23Sale5.3451,756276,470337,644May 09 08:32 AM
Phelan William LawrenceChief Accounting OfficerMay 02 '23Sale3.805,20019,739185,814May 03 06:26 PM
Carlson Peter MChief Financial OfficerApr 25 '23Sale3.746,09422,816662,411Apr 27 07:21 PM
Hulse William Frank IVGeneral Counsel and CAOApr 25 '23Sale3.745,98822,419462,434Apr 27 07:23 PM
Stein Robert BenjaminPresident, Regenerative Med.Apr 25 '23Sale3.745,98722,415389,400Apr 27 07:24 PM
Phelan William LawrenceChief Accounting OfficerApr 25 '23Sale3.741,6286,095191,014Apr 27 07:25 PM